This inventor holds 8 USPTO granted patents and 1 published patent application. Top assignee: Cody Laboratories, Inc.. Active years: 2014-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2019
Title: Iouri Voitsekhovski: Innovator in Pharmaceutical Chemistry
Introduction
Iouri Voitsekhovski is a notable inventor based in Cody, Wyoming, who has made significant contributions to the field of pharmaceutical chemistry. With a total of 8 patents to his name, he has focused on developing innovative methods for the synthesis of important opioid compounds.
Latest Patents
Among his latest patents is a method for the conversion of oxycodone base to oxycodone hydrochloride. This synthetic method provides an improved impurity profile for oxycodone and its salts. The process involves converting thebaine to a 14-hydroxycodeinone sulfate intermediate, which minimizes the presence of a 7,8-dihydro-8,14-dihydroxycodeinone impurity. Additionally, Voitsekhovski has developed efficient methods for the catalytic preparation of hydromorphone and hydrocodone. These methods utilize redox isomerization of morphine or codeine allylic alcohols, employing transition metal aminophosphine catalysts formed in situ.
Career Highlights
Iouri Voitsekhovski is currently associated with Cody Laboratories, Inc., where he continues to advance his research in pharmaceutical synthesis. His work has been instrumental in improving the quality and efficacy of opioid medications.
Collaborations
Throughout his career, Voitsekhovski has collaborated with esteemed colleagues, including Zinovy Itov and Vladimir F Kuznetsov. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Iouri Voitsekhovski's contributions to pharmaceutical chemistry through his patents and research have made a significant impact on the field. His innovative approaches to synthesis continue to pave the way for advancements in medication development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile